Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00145600 · ClinicalTrials.gov registry record · Phase 2
Therapy for Pediatric Hodgkin Lymphoma
A Phase 2 study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 296
- Enrollment target
NCT00145600: Completed Phase 2 study, sponsored by St. Jude Children's Research Hospital.
NCT00145600 is a Phase 2 study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 296 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (123% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00145600, a Phase 2 study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 296 participants
- Enrollment target
Study Summary
With the success of current chemotherapy for Hodgkin's disease, the goal of this protocol is to maintain the currently successful cure rate and reduce treatment related side effects and long term toxicity. The main purpose of this study is to estimate the event free survival of patients treated with risk-adapted therapy compared to historical controls.
Primary Outcome
Event-free survival (EFS) is based on the time from protocol enrollment to the occurrence of first event (relapse or progressive disease, subsequent malignancy, or death from any cause). Patients not experiencing an event are censored at their last follow-up date. Event-free Survival Probability will be estimated by Kaplan-Meier (KM) method with a 95% confidence interval calculated using the Greenwood's formula.
Interventions
- DRUG 12 Week Stanford V Chemotherapy
- DRUG 4 cycles of VAMP chemotherapy
- DRUG 2 alternating cycles of VAMP/COP chemotherapy
- DRUG 3 alternating cycles of VAMP/COP chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 296 participants |
| Start Date | 2000-03-02 |
| Est. Completion | 2021-11-05 |
| Phase | Phase 2 |
What the finished NCT00145600 record still lists
NCT00145600 is an interventional study that assigns participants to a tested intervention. The registered 296 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (123% higher).
The record links to 0 conditions, and to 4 interventions - of which 12 Week Stanford V Chemotherapy is the first listed.
NCT00145600 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00145600 about?
NCT00145600 is a clinical study titled "Therapy for Pediatric Hodgkin Lymphoma". With the success of current chemotherapy for Hodgkin's disease, the goal of this protocol is to maintain the currently successful cure rate and reduce treatment related side effects and long term toxicity. The main purpose of this study is to estimate the event free survival of patients treated with...
What is the current status of trial NCT00145600?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 296 participants. The study started on 2000-03-02. Estimated completion is 2021-11-05.
What interventions are being tested in trial NCT00145600?
The interventions under investigation include: 12 Week Stanford V Chemotherapy (DRUG), 4 cycles of VAMP chemotherapy (DRUG), 2 alternating cycles of VAMP/COP chemotherapy (DRUG), 3 alternating cycles of VAMP/COP chemotherapy (DRUG).
Who is sponsoring clinical trial NCT00145600?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00145600's enrollment target sits among peer trials
296 189th of 2000 higher than 1,812 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05563792 · 296 participants · NA
Options for Pain Management Using Nonpharmacological Strategies
- NCT06828445 · 296 participants · Phase 1
Increasing Affordable Fruits and Vegetables for Families With Food Insecurity
- NCT06920563 · 296 participants · NA
Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education
- NCT06309160 · 297 participants · NA
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI